"10.1371_journal.pone.0060047","plos one","2013-03-28T00:00:00Z","Liliana Scorzoni; Maria Pilar de Lucas; Ana Cecilia Mesa-Arango; Ana Marisa Fusco-Almeida; Encarnación Lozano; Manuel Cuenca-Estrella; Maria Jose Mendes-Giannini; Oscar Zaragoza","Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain; Laboratório de Micologia Clínica, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista de São Paulo, Araraquara, Brazil; Department of Cellular Biology, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain; Group of Investigative Dermatology, University of Antioquia, Medellín, Colombia","Conceived and designed the experiments: LS MPL EL MCE MJMG OZ. Performed the experiments: LS MPL ACMA EL. Analyzed the data: LS MPL ACMA EL OZ. Contributed reagents/materials/analysis tools: EL MCE OZ. Wrote the paper: LS MPL ACMA AMFA EL MCE MJMG OZ.","The authors have the following interests: In the past 5 years, M.C.E. has received grant support from Astellas Pharma, bioMerieux, Gilead Sciences, Merck Sharp and Dohme, Pfizer, Schering Plough and Soria Melguizo SA. He has been an advisor/consultant to Gilead Sciences, Merck Sharp and Dohme, Pfizer, and Schering Plough. He has been paid for talks on behalf of Gilead Sciences, Merck Sharp and Dohme, Pfizer, and Schering Plough. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","03","Liliana Scorzoni","LS",8,TRUE,6,4,5,8,TRUE,TRUE,FALSE,0,NA,FALSE
